MeCP2 binds to 5hmc enriched within active genes and accessible chromatin in the nervous system
Reads0
Chats0
TLDR
In this paper, a quantitative, genome-wide analysis of 5hmC, 5-methylcytosine (5mC), and gene expression in differentiated CNS cell types in vivo is presented.Abstract:
SUMMARY The high level of 5-hydroxymethylcytosine (5hmC) present in neuronal genomes suggests that mechanisms interpreting 5hmC in the CNS may differ from those present in embryonic stem cells. Here, we present quantitative, genome-wide analysis of 5hmC, 5-methylcytosine (5mC), and gene expression in differentiated CNS cell types in vivo. We report that 5hmC is enriched in active genes and that, surprisingly, strong depletion of 5mC is observed over these regions. The contribution of these epigenetic marks to gene expression depends critically on cell type. We identify methyl-CpG-binding protein 2 (MeCP2) as the major 5hmC-binding protein in the brain and demonstrate that MeCP2 binds 5hmC- and 5mC-containing DNA with similar high affinities. The Rett-syndrome-causing mutation R133C preferentially inhibits 5hmC binding. These findings support a model in which 5hmC and MeCP2 constitute a cell-specific epigenetic mechanism for regulation of chromatin structure and gene expression.read more
Citations
More filters
Journal Article
MiR-520b inhibits the development of glioma by directly targeting MBD2.
TL;DR: This is the first study to demonstrate that miR-520b functions as a tumor suppressor in glioma by directly targeting methyl-CpG-binding domain 2 (MBD2), suggesting that MBD2 may be a potential therapeutic target for gliomas.
Journal ArticleDOI
An epigenetic view of developmental diseases: new targets, new therapies.
TL;DR: The present review summarizes the recent progress about the function of epigenetic regulation, especially DNA and RNA modifications in developmental diseases, and suggests that epigenetic components could serve as novel targets for the treatment of developmental diseases.
Journal ArticleDOI
Age-related epigenome-wide DNA methylation and hydroxymethylation in longitudinal mouse blood
Joseph Kochmanski,Elizabeth H. Marchlewicz,Raymond G. Cavalcante,Maureen A. Sartor,Dana C. Dolinoy +4 more
TL;DR: This work tested the hypothesis that 5hmC changes with age, but in a direction opposite to 5-methylcytosine (5mC), potentially playing a distinct role in aging, and identified 28,196 unique differentially methylated CpGs and 8,613 differentially hydroxymethylated regions (DHMRs).
Journal ArticleDOI
MeCP2 Promotes Colorectal Cancer Metastasis by Modulating ZEB1 Transcription.
TL;DR: MeCP2 expression was upregulated in CRC tissues and this upregulation was related to poor prognosis, and MeCP2 suppression may be a promising therapeutic strategy in CRC.
Journal ArticleDOI
Genetic Characterization of Ten-Eleven-Translocation Methylcytosine Dioxygenase Alterations in Human Glioma
Theo F. J. Kraus,Andrea Greiner,Martina Steinmaurer,Vanessa Dietinger,Virginie Guibourt,Hans A. Kretzschmar +5 more
TL;DR: The data emphasize that, in contrast to leukemia, loss of 5hmC in glioma is not caused by TET gene alterations, and other disturbances, such as disrupted gene expressions or functional inhibitions of TET proteins may be responsible for the aberrant epigenome of humanglioma.
References
More filters
Journal ArticleDOI
Differential expression analysis for sequence count data.
Simon Anders,Wolfgang Huber +1 more
TL;DR: A method based on the negative binomial distribution, with variance and mean linked by local regression, is proposed and an implementation, DESeq, as an R/Bioconductor package is presented.
Journal ArticleDOI
Mapping and quantifying mammalian transcriptomes by RNA-Seq.
TL;DR: Although >90% of uniquely mapped reads fell within known exons, the remaining data suggest new and revised gene models, including changed or additional promoters, exons and 3′ untranscribed regions, as well as new candidate microRNA precursors.
Journal ArticleDOI
Bioconductor: open software development for computational biology and bioinformatics
Robert Gentleman,Vincent J. Carey,Douglas M. Bates,Benjamin M. Bolstad,Marcel Dettling,Sandrine Dudoit,Byron Ellis,Laurent Gautier,Yongchao Ge,Jeff Gentry,Kurt Hornik,Torsten Hothorn,Wolfgang Huber,Stefano Maria Iacus,Rafael A. Irizarry,Friedrich Leisch,Cheng Li,Martin Maechler,A. J. Rossini,Günther Sawitzki,Colin A. Smith,Gordon K. Smyth,Luke Tierney,Jean Yang,Jianhua Zhang +24 more
TL;DR: Details of the aims and methods of Bioconductor, the collaborative creation of extensible software for computational biology and bioinformatics, and current challenges are described.
Journal ArticleDOI
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani,Kian Peng Koh,Yinghua Shen,William A. Pastor,Hozefa S. Bandukwala,Yevgeny Brudno,Suneet Agarwal,Lakshminarayan M. Iyer,David R. Liu,L. Aravind,Anjana Rao +10 more
TL;DR: It is shown here that TET1, a fusion partner of the MLL gene in acute myeloid leukemia, is a 2-oxoglutarate (2OG)- and Fe(II)-dependent enzyme that catalyzes conversion of 5mC to 5-hydroxymethylcytosine (hmC) in cultured cells and in vitro.
Journal ArticleDOI
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
Ruthie E. Amir,Ignatia B. Van den Veyver,Mimi Wan,Charles Q. Tran,Uta Francke,Huda Y. Zoghbi +5 more
TL;DR: This study reports the first disease-causing mutations in RTT and points to abnormal epigenetic regulation as the mechanism underlying the pathogenesis of RTT.